Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology

Microbiology and Immunology

Volumn 46, Issue 2, 2002, Pages 89-93

  Toriumi, Yoshimi ^a   Sugita, Takashi ^a   Nakajima, Masamitsu ^b   Matsushima, Toshiharu ^b   Shinoda, Takako ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Amphotericin B; MIC; Trichosporon asahii

Indexed keywords

AMPHOTERICIN B;

ANTIFUNGAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; TRICHOSPORON ASAHII;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; TRICHOSPORON;

FUNGI; TRICHOSPORON ASAHII;

EID: 0036189536     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2002.tb02663.x     Document Type: Article

References (26)

1. Azole therapy for trichosporonosis: Clinical evaluation of eight patients, experimental therapy for murine infection, and review
2. A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology
3. Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans
4. Trichosporon on humans: A practical account
5. Contributions to a revision of the genus Trichosporon
6. Trichosporon infections: Clinical manifestations and treatment
7. Trichosporon beigelii infection: A review
8. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans
9. Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods
10. Evaluation of voriconazole pharmacodynamics using time-kill methodology
11. Evaluation of endpoints for antifungal susceptibility determinations with LY303366
12. Hematogenous trichosporonosis in cancer patients: Report of 12 cases including 5 during prophylaxis with itraconazole
13. Review of trichosporonosis with a report of a case of disseminated Trichosporon asahii infection
14. In vitro susceptibility of Trichosporon beigelii to antifungal agents
15. Efficacy of recombinant human granulocyte-colony stimulating factor alone and in combination with antifungal agents against disseminated trichosporonosis in neutropenic mice
16. Time-kill curves for Cryptococcus neoformans isolated from patients with AIDS
17. Reclassification of Trichosporon cutaneum by DNA relatedness by using the spectrophotometric method and the chemiluminometric method
18. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification
19. Identification of Trichosporon asahii by PCR based on sequences of the internal transcribed spacer regions
20. Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients
21. Disseminated Trichosporon beigelii infection in patients with malignant diseases: Immunohistochemical study and review
22. Central catheter infection by Trichosporon beigelii after autologous blood stem cell transplantation. A case report and review of the literature
23. Disseminated infection with Trichosporon beigelii
24. Trichosporon beigelii, an emerging pathogen resistant to amphotericin
25. Experimental Trichosporon infection in persistently granulocytopenic rabbits: Implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis